<?xml version="1.0" encoding="UTF-8"?>
<p>Recently, the antiparasitic activity of BRP has attracted the attention of researchers. Polymeric nanoparticles of the BRP extract and the ethanolic extract of BRP have demonstrated anti-leishmanial activity against 
 <italic>L</italic>. 
 <italic>(V</italic>.
 <italic>) braziliensis</italic>, with IC
 <sub>50</sub> values of 31.3 μg/mL and 38.0 μg/mL, respectively, demonstrating the potential of BRP in the composition of pharmaceuticals for leishmaniasis therapy [
 <xref rid="pone.0191797.ref012" ref-type="bibr">12</xref>]. Additionally, when ethanolic extracts from various types of green, brown and red propolis from different regions of Brazil were tested against 
 <italic>Trypanosoma cruzi</italic> Y-strain epimastigotes, an inhibitory effect on parasite growth was observed in the first 24 h for all the types of propolis. However, only the ethanolic extracts of BRP presented a persistent 
 <italic>T</italic>. 
 <italic>cruzi</italic>-inhibitory effect after 96 h, suggesting red propolis as a potential alternative for the therapeutic treatment of Chagas disease [
 <xref rid="pone.0191797.ref010" ref-type="bibr">10</xref>].
</p>
